Cargando…

Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis

Roundabout 4 (Robo4) is a transmembrane receptor that expresses specifically in endothelial cells. Soluble Robo4 was reported in the human plasma and mouse serum and is inhibitory towards FGF- and VEGF-induced angiogenesis. It remains unknown how soluble Robo4 is generated and if soluble Robo4 regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Wenyuan, Pinilla-Baquero, Alejandro, Faulkner, John, Song, Xuehong, Prabhakar, Pradeep, Qiu, Hong, Moremen, Kelley W., Ludwig, Andreas, Dempsey, Peter J., Azadi, Parastoo, Wang, Lianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921330/
https://www.ncbi.nlm.nih.gov/pubmed/35288626
http://dx.doi.org/10.1038/s41598-022-08227-8
_version_ 1784669313248002048
author Xiao, Wenyuan
Pinilla-Baquero, Alejandro
Faulkner, John
Song, Xuehong
Prabhakar, Pradeep
Qiu, Hong
Moremen, Kelley W.
Ludwig, Andreas
Dempsey, Peter J.
Azadi, Parastoo
Wang, Lianchun
author_facet Xiao, Wenyuan
Pinilla-Baquero, Alejandro
Faulkner, John
Song, Xuehong
Prabhakar, Pradeep
Qiu, Hong
Moremen, Kelley W.
Ludwig, Andreas
Dempsey, Peter J.
Azadi, Parastoo
Wang, Lianchun
author_sort Xiao, Wenyuan
collection PubMed
description Roundabout 4 (Robo4) is a transmembrane receptor that expresses specifically in endothelial cells. Soluble Robo4 was reported in the human plasma and mouse serum and is inhibitory towards FGF- and VEGF-induced angiogenesis. It remains unknown how soluble Robo4 is generated and if soluble Robo4 regulates additional angiogenic signaling. Here, we report soluble Robo4 is the product of constitutive ectodomain shedding of endothelial cell surface Robo4 by disintegrin metalloproteinases ADAM10 and ADAM17 and acts to inhibit angiogenic Slit3 signaling. Meanwhile, the ligand Slit3 induces cell surface receptor Robo4 endocytosis to shield Robo4 from shedding, showing Slit3 inhibits Robo4 shedding to enhance Robo4 signaling. Our study delineated ADAM10 and ADAM17 are Robo4 sheddases, and ectodomain shedding, including negative regulation by its ligand Slit3, represents a novel control mechanism of Robo4 signaling in angiogenesis.
format Online
Article
Text
id pubmed-8921330
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89213302022-03-16 Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis Xiao, Wenyuan Pinilla-Baquero, Alejandro Faulkner, John Song, Xuehong Prabhakar, Pradeep Qiu, Hong Moremen, Kelley W. Ludwig, Andreas Dempsey, Peter J. Azadi, Parastoo Wang, Lianchun Sci Rep Article Roundabout 4 (Robo4) is a transmembrane receptor that expresses specifically in endothelial cells. Soluble Robo4 was reported in the human plasma and mouse serum and is inhibitory towards FGF- and VEGF-induced angiogenesis. It remains unknown how soluble Robo4 is generated and if soluble Robo4 regulates additional angiogenic signaling. Here, we report soluble Robo4 is the product of constitutive ectodomain shedding of endothelial cell surface Robo4 by disintegrin metalloproteinases ADAM10 and ADAM17 and acts to inhibit angiogenic Slit3 signaling. Meanwhile, the ligand Slit3 induces cell surface receptor Robo4 endocytosis to shield Robo4 from shedding, showing Slit3 inhibits Robo4 shedding to enhance Robo4 signaling. Our study delineated ADAM10 and ADAM17 are Robo4 sheddases, and ectodomain shedding, including negative regulation by its ligand Slit3, represents a novel control mechanism of Robo4 signaling in angiogenesis. Nature Publishing Group UK 2022-03-14 /pmc/articles/PMC8921330/ /pubmed/35288626 http://dx.doi.org/10.1038/s41598-022-08227-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Xiao, Wenyuan
Pinilla-Baquero, Alejandro
Faulkner, John
Song, Xuehong
Prabhakar, Pradeep
Qiu, Hong
Moremen, Kelley W.
Ludwig, Andreas
Dempsey, Peter J.
Azadi, Parastoo
Wang, Lianchun
Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
title Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
title_full Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
title_fullStr Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
title_full_unstemmed Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
title_short Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis
title_sort robo4 is constitutively shed by adams from endothelial cells and the shed robo4 functions to inhibit slit3-induced angiogenesis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921330/
https://www.ncbi.nlm.nih.gov/pubmed/35288626
http://dx.doi.org/10.1038/s41598-022-08227-8
work_keys_str_mv AT xiaowenyuan robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT pinillabaqueroalejandro robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT faulknerjohn robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT songxuehong robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT prabhakarpradeep robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT qiuhong robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT moremenkelleyw robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT ludwigandreas robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT dempseypeterj robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT azadiparastoo robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis
AT wanglianchun robo4isconstitutivelyshedbyadamsfromendothelialcellsandtheshedrobo4functionstoinhibitslit3inducedangiogenesis